Overview

A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids

Status:
Terminated

Trial end date:
2020-10-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to assess the efficacy of idebenone in delaying the loss of respiratory function in patients with DMD receiving concomitant glucocorticoid steroids

Phase:

Phase 3

Details

Lead Sponsor:

Santhera Pharmaceuticals

Treatments:

Glucocorticoids
Idebenone
Ubiquinone